Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

Independence would be good for the FDA and the public
Independence would be good for the FDA and the public
In a moment remarkable for its symbolism, six former Food and Drug Administration commissioners last month sat together on a stage and argued that their former agency needs more autonomy from Washingt...
Home test for malaria, cancer may be coming soon
Home test for malaria, cancer may be coming soon
In a few years, testing yourself for cancer or malaria could be as easy as testing your blood sugar or taking a home pregnancy test, according to a recent study.
BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer Inc
BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer Inc
CAMBRIDGE, Mass.
Roche’s marketing applications for review of OCREVUS® (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA
Roche’s marketing applications for review of OCREVUS® (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA
Basel, 28 June 2016    OCREVUS is the first investigational medicine seeking marketing authorisation for both relapsing and primary progressive multiple sclerosis (MS) ...
Hungary's Richter buys Swiss biotech company Finox for $194 mln
Hungary's Richter buys Swiss biotech company Finox for $194 mln
BUDAPEST, June 30 (Reuters) - Hungarian drugmaker Richter has acquired Swiss biotech company Finox Holding for 190 million Swiss francs ($194 million), expanding its presence in major ...
Tesaro's ovarian cancer drug study succeeds, shares soar
Tesaro's ovarian cancer drug study succeeds, shares soar
Tesaro Inc said its experimental ovarian cancer drug niraparib met the main goal of prolonging survival in patients, without the disease worsening, in a late-stage trial, sending its shares to a recor...
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections
AstraZeneca today announced that the European Commission (EC) has granted marketing authorisation for Zavicefta (ceftazidime-avibactam, previously known as CAZ AVI), a new combination ...
U.S. Food and Drug Administration Approves Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C
U.S. Food and Drug Administration Approves Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C
FOSTER CITY, Calif.
Sanofi, Boehringer Ingelheim Agree to $25 Billion Asset Swap
Sanofi, Boehringer Ingelheim Agree to $25 Billion Asset Swap
Boehringer to get animal-health unit, pay 4.
After 190 Tries, Are We Any Closer to a Cure for Alzheimer’s?
After 190 Tries, Are We Any Closer to a Cure for Alzheimer’s?
Eli Lilly has spent almost three decades working on drugs for Alzheimer’s disease with not much to show for it yet.
GW Pharmaceuticals plc announces positive results of the Phase 3 clinical trial of its investigational medicine Epidiolex® for the treatment of Lennox-Gastaut syndrome
GW Pharmaceuticals plc announces positive results of the Phase 3 clinical trial of its investigational medicine Epidiolex® for the treatment of Lennox-Gastaut syndrome
London, UK; 27 June 2016.
Daiichi Sankyo Enters Into Agreement with Servier Canada For Factor Xa Inhibitor Edoxaban
Daiichi Sankyo Enters Into Agreement with Servier Canada For Factor Xa Inhibitor Edoxaban
TOKYO, Japan (June 27, 2016) – Daiichi Sankyo Co.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand